June 29, 2017
AZ, Chi-Med in final stage clinical trial with cancer drug
AstraZeneca and Chi-Med said on Thursday they kicked off the third phase of clinical testing of their cancer drug.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Chi-Med
February 14, 2017
Chi-Med kicks off human testing of its anti-tumor inhibitor
Hutchison China MediTech Limited (Chi-Med) has kicked off today in Australia the first-in-human (FIH) Phase I clinical testing of inhibitor HMPL-453, for fibroblast growth factor receptor signaling pathway, which forces tumor growth.
January 16, 2017
Two directors resign, one replacement for several committee spots
Hutchison China MediTech has appointed Paul Rutherford Carter as its Senior Independent Non-Executive Director, and a member of several its…
January 16, 2017
Chi-Med kicks off two cancer drug studies in China
AIM and Nasdaq listed pharmaceutical company, Hutchison China MediTech Limited (Chi-Med) has initiated two Phase II studies in China for testing cancer treatments.